InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,537.02
(
0.51%
)
US TECH 100
19,641.60
(
0.83%
)
Dow Jones
39,308.00
(
-0.06%
)
Brent Oil
87.00
(
0.10%
)
Bitcoin
57,244.60
(
-4.85%
)
Post# of 648861
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

lukin4winners

Send PM Follow Ignore
Followers 799
Posts 118388
Boards Moderated 0
Alias Born 11/20/2004

lukin4winners

Re: None

Thursday, 12/15/2022 10:37:21 AM

Thursday, December 15, 2022 10:37:21 AM

Post# of 648861
TCDA .155 one of 15 most shorted 40% Tricida, Inc. (NASDAQ:TCDA) is a California-based pharmaceutical company. It focuses on the development and commercialization of veverimer (TRC101), a non-absorbed orally-administered polymer that has completed Phase III trial to treat metabolic acidosis in patients with chronic kidney disease by binding and removing acid from the gastrointestinal track.

Among the hedge funds being tracked by Insider Monkey, New York-based investment firm OrbiMed Advisors is a leading shareholder in Tricida, Inc. (NASDAQ:TCDA) with 10.2 million shares worth more than $99 million.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up